Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma
Authors:
- A. GabrieleAGA. Gabriele
- F. LandoniFLF. Landoni
- C. MangioniCMC. Mangioni
- C. SessaCSC. Sessa
Open Access
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (10) , 969-972
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Intense Neoadjuvant Chemotherapy with Cisplatin and Epirubicin for Advanced or Bulky Cervical and Vaginal AdenocarcinomaGynecologic Oncology, 1997
- Phase II study of paclitaxel as salvage treatment in advanced endometrial cancerAnnals of Oncology, 1996
- A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.Journal of Clinical Oncology, 1986
- Reporting results of cancer treatmentCancer, 1981